Vivani Medical, Inc.
NASDAQ:VANIMedical - Devices
+$0.02 today
- Market cap
- $94.71M
- Beta
- 3.29
- P/E (TTM)
- -3.5
- EPS (TTM)
- -$0.33
Volume 0.18M
Average 0.24M
VANI Total Equity
Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.
Vivani Medical, Inc.NASDAQ: VANI
Total Equity · Q1 FY2026 · quarter ended Mar 2026
Total equity rises 64.2% from a year ago
Total equity stood at $19.09M at the end of Q1 FY2026, up 64.2% from a year earlier and up 21.3% from the prior quarter. Over 3 fiscal years it compounded at -29.2% a year.
Context
- Total equity amounted to 45.1% of total assets at the end of Q1 FY2026, up 12.3 pp from a year earlier.
- Total equity increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether total equity keeps rising in the next quarterly balance sheet after a +64.2% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Equity history
USD · from the balance sheet
- Latest · FY2025
- 15.73M USD
- Year-over-year change
- -10.7%
- 4-year CAGR
- +58.9%
| Period | Period end | Total Equity | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 15.73M | -10.7% |
| FY2024 | 2024-12-31 | 17.61M | -15.2% |
| FY2023 | 2023-12-31 | 20.76M | -53.1% |
| FY2022 | 2022-12-31 | 44.31M | +1697.5% |
| FY2021 | 2021-12-31 | 2.47M | — |
Total Equity vs competitors
How VANI compares with its peers on the latest reported figures
- Peers report in different currencies, so total equity is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +64.2% is the 3rd highest of 8, against a peer median of +4.3%.
- Total equity amounts to 45.1% of total assets for VANI, versus a peer median of 77.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $238.28M USD | +70.3% | +9.7% | 88.6% | |
| Mar 2026 | $164.46M USD | +2.6% | +3.1% | 75.0% | |
IMAImageneBio Inc | Mar 2026 | $123.33M USD | +4.3% | -3.2% | 90.2% |
| Mar 2026 | $74.11M USD | +156.0% | +119.9% | 94.9% | |
| Mar 2026 | $34.36M USD | -20.3% | -30.8% | 56.9% | |
| Mar 2026 | CA$24.27M CAD | +38.0% | -22.6% | 77.1% | |
| Mar 2026 | $19.09M USD | +64.2% | -29.2% | 45.1% | |
| Mar 2026 | -$23.17M USD | -406.8% | — | 44.9% | |
| Peer median (excluding VANI) | — | +4.3% | -0.1% | 77.1% | |
Competitors are the stored peer set for VANI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Vivani Medical, Inc.
NASDAQ:VANI
Intrinsic Alpha fair value
Locked
Current Price
$1.05
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.